SCIEX (MA, USA), a global leader in life science analytical technology, recently announced the launch of the next generation of their flagship nominal mass spectrometer, the SCIEX Triple Quad™ 7500 LC-MS/MS System – QTRAP® Ready.
At ASMS 2020 Reboot, SCIEX (MA, USA) presented the new Echo® MS system. The system, which uses a proprietary acoustic ejection technology, promises ultrahigh throughput and high-quality data.
This poster from SCIEX (Warrington, UK) reports the use of an immunoaffinity high-resolution accurate mass assay as a complimentary analytical technique for signature peptide quantification.
This presentation from SCIEX (Warrington, UK) explores why we need high-resolution accurate mass spectrometry quantification, discussing topics ranging from the desire for higher selectivity in complex matrices to the need to analyze multiple charge states and fragment ions.
In this podcast, Jason Causon (Technical Product Manager at SCIEX, Canada) discusses his experience with HRMS and the current research focuses at SCIEX. He also details how SCIEX are using HRMS, the biggest challenges that have had to be overcome and future opportunities that he hopes HRMS software will bring.
Hear more about the recent mass spectrometry product launches from SCIEX announced at ASMS 2019, including the new Acoustic Ejection Mass Spectrometry technology, in this interview with Neil Walsh (SCIEX; MA, USA).
We present a rare opportunity to see experts from across the pharmaceutical and CRO industries sharing perspectives on FDA guidance, transitioning skills and future hopes for the bio lab.
Soup to Nuts of Large Molecule LC–MS/MS Bioanalysis: From In Silico to Sample Preparation, Microflow and Optimal Source Design
Webinar available to view on demand. In this case study, Alturas Analytics (ID, USA) presents the techniques they use in their labs for optimal analysis of large molecules from biological matrices.
SCIEX announces innovations in their ultra low-flow separation and accurate mass analysis, capillary electrophoresis–mass spectrometry (CESI-MS) technology and LGC announces investment plans in new GMP analytical capability.
Available to view on demand. We present a rare opportunity to see experts from across the pharmaceutical and CRO industries sharing perspectives on new technology integration in the field of bioanalysis.